Once a relatively obscure class of drugs used for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects over 100 million Americans. Horizons moderator ...

Also, for the first time, doctors are advised to test for two biomarkers in the blood that have been linked to increased risks of heart disease.

The test can help assess your lifetime risk for cardiovascular disease. That, along with earlier treatment for high cholesterol, is part of new doctors' guidelines.

Dyslipidemia is highly prevalent and the primary direct driver of atherosclerotic CVD. In the more than 7 years since the last American Heart Association/American College of Cardiology/Multisociety ...

Twenty point six percent of patients followed a switcher trajectory within 12 months, with higher persistence seen for switchers.

Junk Food May Erode Bones Long Before Old Age, Study Finds In A Nutshell A 12-year study of more than 163,000 adults found ...

Back in the early 1970s, psychologists at Northwestern University performed an experiment that, on the surface, looked like a child’s fantasy. The researchers gathered 45 college women and asked some ...

FDA now permits Arexvy for adults 18–49 with elevated RSV risk from conditions such as chronic cardiopulmonary or renal disease, obesity, and diabetes. Epidemiology in U.S. adults 18–49 includes ...

Bariatric surgery uptake has decreased since the fourth quarter of 2022, coinciding with a rise in prescriptions of semaglutide and tirzepatide for adults with obesity, according to a research letter ...

A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid ...

This week, Mad in America examines three studies around mental health diagnosis, psychotropic drug use, obesity, and diabetes ...

Metro Creative The prevalence of obesity among adults 60 and older is significant. According to the Centers for Disease ...